RecruitingNCT07587216

Prospective Clinical Database Construction for Liver Cancer Diagnosis and Treatment


Sponsor

Tongji Hospital

Enrollment

800 participants

Start Date

Jan 1, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

This study is a prospective, observational, real-world cohort study. We aim to establish a prospective database in the Department of Hepatobiliary and Pancreatic Surgery, systematically collecting and integrating patients' full-course diagnostic and therapeutic information along with long-term outcomes. This will enable objective evaluation of prognosis and treatment efficacy in real-world clinical practice, while providing a data foundation and evidence support for subsequent optimization of clinical decision-makin


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • Male or female aged ≥18 years at the time of signing the informed consent form
  • Clinically or histologically confirmed diagnosis of liver cancer
  • Recieving treatment and follow-up in Tongji Hospital

Exclusion Criteria1

  • \- Refuse participanting in this study

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREliver resection

Patients undergo liver resection for tumor.

DRUGSystemic therapy combined with locoregional interventions

Patients recieve PD-1 inhibitors combined with targeted drugs and locoregional interventions


Locations(1)

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

Wuhan, Hubei, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07587216


Related Trials